Low Nicotine Cigarettes for Smoking
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests how low-nicotine cigarettes (Low Nicotine Standard) and changes in tobacco prices influence buying habits and the use of alternatives like e-cigarettes. The goal is to understand whether smokers might switch to illegal products or other nicotine sources when faced with these changes. It involves two groups: those who only smoke cigarettes and those who use both cigarettes and e-cigarettes. The trial suits individuals who smoke at least 10 cigarettes a day and have stable smoking habits. As an unphased trial, it provides a unique opportunity to contribute to research that could shape future tobacco policies.
Do I have to stop taking my current medications for the trial?
The trial requires that you do not take any tobacco cessation medications or medications that interfere with nicotine metabolism, motivation, or reinforcement.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that low nicotine cigarettes are generally easy for people to use. In earlier studies, individuals who smoked very-low-nicotine cigarettes (VLNC) smoked fewer cigarettes daily and had lower carbon monoxide levels in their breath, indicating reduced intake of harmful chemicals. They also reported fewer cravings and found smoking less enjoyable.
Another study found that people using VLNC cigarettes had better overall outcomes related to smoking compared to those using regular nicotine cigarettes. This suggests that the low nicotine version is safe to use and might even help reduce smoking habits.
These findings indicate that VLNC cigarettes are a safe choice for those wanting to lower their nicotine intake. However, consulting a healthcare provider before changing smoking habits is always advisable.12345Why are researchers excited about this trial?
Researchers are excited about the trial for low nicotine cigarettes because it explores a novel approach to smoking cessation. Unlike conventional cigarettes, which contain higher levels of nicotine, these low nicotine options aim to reduce nicotine dependence by delivering significantly less nicotine. This could potentially lead to decreased addiction levels and make it easier for smokers to quit. Additionally, by examining the impact of tobacco pricing, researchers hope to understand how financial factors might influence smoking habits. This dual approach could offer fresh insights into reducing smoking rates more effectively than current methods.
What evidence suggests that this trial's treatments could be effective for smoking?
Research has shown that lowering nicotine levels in cigarettes makes them much less addictive. In this trial, participants will use low nicotine cigarettes. Studies have found that cigarettes with very low nicotine (VLNCs) increase the confidence of smokers who want to quit, often leading to better success in quitting. Smokers who switch to VLNCs also tend to smoke fewer cigarettes over time. The aim is to reduce reliance on nicotine, which can help decrease overall smoking rates.26789
Who Is on the Research Team?
Roberta Freitas-Lemos, PhD
Principal Investigator
Fralin Biomedical Research Institute at Virginia Tech Carilion
Are You a Good Fit for This Trial?
This trial is for individuals who use cigarettes or e-cigarettes. Specific eligibility criteria are not provided, but typically participants must be of legal smoking age and may need to meet certain health conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Assessment
Participants complete an assessment session to evaluate baseline characteristics and preferences
Experimental Tobacco Marketplace (ETM) Session
Participants engage in scenarios within the ETM to assess purchasing behaviors under different conditions
Follow-up
Participants are contacted for a follow-up phone call to discuss their experiences and any changes in behavior
What Are the Treatments Tested in This Trial?
Interventions
- Low Nicotine Standard
- Tobacco Prices
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Polytechnic Institute and State University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Medical University of South Carolina
Collaborator